Docusate Sodium 100mg Capsule, Liquid Filled
Product Images NDC 53345-029

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Docusate Sodium 100mg (NDC 53345-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dss 100 mg Red Bulk Label 15000ct

The text provides a product description for Docusate Sodium Capsules 100 mg manufactured by Humanwell PuraCap Pharmaceutical in Wuhan, China. The capsules come in a bulk shipment of 15,000 capsules, with a lot number and manufacturing date indicated. The product code is 43-01655 and each capsule contains 100 mg of Docusate Sodium. The caution advises against further manufacturing, processing, or repackaging. The box should be inspected upon receipt, protected from heat, humidity and light, and stored at 15-30°C or 59-36°F.*

FDA Label Image

Dss 100 mg Red Bulk Label 20000ct

Hunasvell PuaCap Pharmaceutical (Wuhan) Ltd. is a manufacturer of Deocusate Sodiwun Capsules containing Docusate Sodim 100 mg. The product is delivered in bulk, intended for further processing. The recommended storage temperature is 15-30°C (59-86T'). The lot number is REXXKRK XYYy, manufactured on October 20, 2014. This information is provided on the product's packaging, which also bears the NDC No.: 5§3345-029-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.